Access Advocates Urge 11th Hour WTO Action on COVID IP Waiver – COVAX Strikes World Bank Deal on Vaccine Finance 26/07/2021 Elaine Ruth Fletcher Vaccine access advocates issued increasingly desperate, last minute calls upon the World Trade Organization to take action over a stalled initiative to impose a temporary waiver on intellectual property for COVID medicines, tests and vaccines – even as the initiative appeared doomed to a stalemate for the rest of the summer. Ahead of the opening […] Continue reading -> Chinese Sinopharm and Sinovac Vaccines to Replenish Global COVAX Facility Supplies 12/07/2021 Editorial team Gavi, the Vaccine Alliance has signed advanced purchase agreements (APAs) with Sinopharm and Sinovac, Chinese biotech firms, to immediately begin supplying the global COVAX Facility with 110 million doses of COVID-19 vaccines, the agency announced on Monday. The agreements come as the Delta variant, first identified in India and classified as a WHO variant of […] Continue reading -> As Africa Experiences ‘Worst Pandemic Week’, COVAX Promises Accelerated Delivery of Vaccines from September 08/07/2021 Paul Adepoju As Africa recorded its worst pandemic week, the COVAX Facility announced on Thursday that it has taken steps to quickly resume the delivery of vaccines to African countries including diversifying its portfolio of COVID-19 vaccines. Aurélia Nguyen, Managing Director of the COVAX Facility based at Gavi, the Vaccine Alliance, said the COVAX portfolio now consists […] Continue reading -> WHO Challenges Pfizer and Moderna to Openly Share Their Know-How to Accelerate COVID Vaccine Production 02/07/2021 Elaine Ruth Fletcher In his most explicit appeal to date, WHO’s Director General Dr Tedros Adhanom Ghebreyesus called upon the global leaders in COVID mRNA vaccine manufacturing – Pfizer/BioNTech and Moderna to “share their know-how” in vaccine manufacturing with more manufacturers, particularly in low- and middle-income countries. The WHO DG also called upon countries that are beginning to […] Continue reading -> COVAX Shortcomings Under Microscope Ahead of Gavi, Vaccine Alliance Board Meeting 22/06/2021 Elaine Ruth Fletcher & Svĕt Lustig Vijay As the board of Gavi, The Vaccine Alliance is set to meet this Wednesday and Thursday, the COVAX global vaccine facility – a cornerstone of the global health sector response on vaccine access – is coming under increased fire for its shortcomings. A bitter opinion piece by Médecins Sans Frontières, published today, has called for […] Continue reading -> BREAKING – United States Unveils Global Vaccine Sharing Scheme for 80 Million Doses by End June 03/06/2021 Editorial team United States President Joe Biden on Thusday unveiled a detailed strategy for sharing 80 million surplus US COVID-19 vaccine doses with other countries in need by the end of June. A detailed allocation plan for the first 25 million of those vaccine doses calls for sharing 75% through the WHO-cosponsored COVAX global vaccine facility – […] Continue reading -> Sustainable COVAX Vaccine Funding & Voluntary Manufacturing Licenses are Better Solutions than IP Waiver, Says IFPMA Head 16/05/2021 Elaine Ruth Fletcher In preparation for the next pandemic, the COVAX global vaccine facility “needs a pot of money, where they can be early movers” in competing for, and securing, vaccine doses. That could help scenarios like the ones seen recently, in which rich countries cornered the market on the first available COVID-19 vaccines, leading to severe shortages […] Continue reading -> Moderna Signs Landmark Agreement With COVAX For 500 Million mRNA Vaccine Doses – WHO Asks G7 For US$20 Billion In COVID Finance 03/05/2021 Svĕt Lustig Vijay Gavi, The Vaccine Alliance, has secured half a billion doses of Moderna’s mRNA vaccine for the COVAX global vaccine facility in a landmark agreement that will deepen vaccination coverage in poor countries around the world, Gavi said on Monday. Meanwhile, Sweden announced that it will donate one million doses of the AstraZeneca vaccine to the […] Continue reading -> China May Become World’s Biggest Vaccine Supplier As India Defaults On Global Deliveries 28/04/2021 Kerry Cullinan As India restricts COVID-19 vaccine exports to address its domestic surge, the World Health Organization (WHO) is poised to give the Chinese vaccine, Sinopharm, emergency use listing (EUL) this week – potentially catapulting China into becoming the biggest global supplier of COVID-19 vaccines for low- and middle-income countries (LMIC). However, Sinopharm is reported to be […] Continue reading -> Ambitious Push to Resume Routine Immunisations to Save 50 Million Lives – COVAX Waits for Indian Vaccines 26/04/2021 Kerry Cullinan Fifty countries have not yet resumed routine immunisations disrupted by the COVID-19 pandemic, affecting 228 million people – mainly children – and there have already been serious measles outbreaks in Yemen, Pakistan and the Democratic Republic of the Congo, according to World Health Organization (WHO) director general Dr Tedros Adhanom Ghebreyusus. To address this, the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Chinese Sinopharm and Sinovac Vaccines to Replenish Global COVAX Facility Supplies 12/07/2021 Editorial team Gavi, the Vaccine Alliance has signed advanced purchase agreements (APAs) with Sinopharm and Sinovac, Chinese biotech firms, to immediately begin supplying the global COVAX Facility with 110 million doses of COVID-19 vaccines, the agency announced on Monday. The agreements come as the Delta variant, first identified in India and classified as a WHO variant of […] Continue reading -> As Africa Experiences ‘Worst Pandemic Week’, COVAX Promises Accelerated Delivery of Vaccines from September 08/07/2021 Paul Adepoju As Africa recorded its worst pandemic week, the COVAX Facility announced on Thursday that it has taken steps to quickly resume the delivery of vaccines to African countries including diversifying its portfolio of COVID-19 vaccines. Aurélia Nguyen, Managing Director of the COVAX Facility based at Gavi, the Vaccine Alliance, said the COVAX portfolio now consists […] Continue reading -> WHO Challenges Pfizer and Moderna to Openly Share Their Know-How to Accelerate COVID Vaccine Production 02/07/2021 Elaine Ruth Fletcher In his most explicit appeal to date, WHO’s Director General Dr Tedros Adhanom Ghebreyesus called upon the global leaders in COVID mRNA vaccine manufacturing – Pfizer/BioNTech and Moderna to “share their know-how” in vaccine manufacturing with more manufacturers, particularly in low- and middle-income countries. The WHO DG also called upon countries that are beginning to […] Continue reading -> COVAX Shortcomings Under Microscope Ahead of Gavi, Vaccine Alliance Board Meeting 22/06/2021 Elaine Ruth Fletcher & Svĕt Lustig Vijay As the board of Gavi, The Vaccine Alliance is set to meet this Wednesday and Thursday, the COVAX global vaccine facility – a cornerstone of the global health sector response on vaccine access – is coming under increased fire for its shortcomings. A bitter opinion piece by Médecins Sans Frontières, published today, has called for […] Continue reading -> BREAKING – United States Unveils Global Vaccine Sharing Scheme for 80 Million Doses by End June 03/06/2021 Editorial team United States President Joe Biden on Thusday unveiled a detailed strategy for sharing 80 million surplus US COVID-19 vaccine doses with other countries in need by the end of June. A detailed allocation plan for the first 25 million of those vaccine doses calls for sharing 75% through the WHO-cosponsored COVAX global vaccine facility – […] Continue reading -> Sustainable COVAX Vaccine Funding & Voluntary Manufacturing Licenses are Better Solutions than IP Waiver, Says IFPMA Head 16/05/2021 Elaine Ruth Fletcher In preparation for the next pandemic, the COVAX global vaccine facility “needs a pot of money, where they can be early movers” in competing for, and securing, vaccine doses. That could help scenarios like the ones seen recently, in which rich countries cornered the market on the first available COVID-19 vaccines, leading to severe shortages […] Continue reading -> Moderna Signs Landmark Agreement With COVAX For 500 Million mRNA Vaccine Doses – WHO Asks G7 For US$20 Billion In COVID Finance 03/05/2021 Svĕt Lustig Vijay Gavi, The Vaccine Alliance, has secured half a billion doses of Moderna’s mRNA vaccine for the COVAX global vaccine facility in a landmark agreement that will deepen vaccination coverage in poor countries around the world, Gavi said on Monday. Meanwhile, Sweden announced that it will donate one million doses of the AstraZeneca vaccine to the […] Continue reading -> China May Become World’s Biggest Vaccine Supplier As India Defaults On Global Deliveries 28/04/2021 Kerry Cullinan As India restricts COVID-19 vaccine exports to address its domestic surge, the World Health Organization (WHO) is poised to give the Chinese vaccine, Sinopharm, emergency use listing (EUL) this week – potentially catapulting China into becoming the biggest global supplier of COVID-19 vaccines for low- and middle-income countries (LMIC). However, Sinopharm is reported to be […] Continue reading -> Ambitious Push to Resume Routine Immunisations to Save 50 Million Lives – COVAX Waits for Indian Vaccines 26/04/2021 Kerry Cullinan Fifty countries have not yet resumed routine immunisations disrupted by the COVID-19 pandemic, affecting 228 million people – mainly children – and there have already been serious measles outbreaks in Yemen, Pakistan and the Democratic Republic of the Congo, according to World Health Organization (WHO) director general Dr Tedros Adhanom Ghebreyusus. To address this, the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
As Africa Experiences ‘Worst Pandemic Week’, COVAX Promises Accelerated Delivery of Vaccines from September 08/07/2021 Paul Adepoju As Africa recorded its worst pandemic week, the COVAX Facility announced on Thursday that it has taken steps to quickly resume the delivery of vaccines to African countries including diversifying its portfolio of COVID-19 vaccines. Aurélia Nguyen, Managing Director of the COVAX Facility based at Gavi, the Vaccine Alliance, said the COVAX portfolio now consists […] Continue reading -> WHO Challenges Pfizer and Moderna to Openly Share Their Know-How to Accelerate COVID Vaccine Production 02/07/2021 Elaine Ruth Fletcher In his most explicit appeal to date, WHO’s Director General Dr Tedros Adhanom Ghebreyesus called upon the global leaders in COVID mRNA vaccine manufacturing – Pfizer/BioNTech and Moderna to “share their know-how” in vaccine manufacturing with more manufacturers, particularly in low- and middle-income countries. The WHO DG also called upon countries that are beginning to […] Continue reading -> COVAX Shortcomings Under Microscope Ahead of Gavi, Vaccine Alliance Board Meeting 22/06/2021 Elaine Ruth Fletcher & Svĕt Lustig Vijay As the board of Gavi, The Vaccine Alliance is set to meet this Wednesday and Thursday, the COVAX global vaccine facility – a cornerstone of the global health sector response on vaccine access – is coming under increased fire for its shortcomings. A bitter opinion piece by Médecins Sans Frontières, published today, has called for […] Continue reading -> BREAKING – United States Unveils Global Vaccine Sharing Scheme for 80 Million Doses by End June 03/06/2021 Editorial team United States President Joe Biden on Thusday unveiled a detailed strategy for sharing 80 million surplus US COVID-19 vaccine doses with other countries in need by the end of June. A detailed allocation plan for the first 25 million of those vaccine doses calls for sharing 75% through the WHO-cosponsored COVAX global vaccine facility – […] Continue reading -> Sustainable COVAX Vaccine Funding & Voluntary Manufacturing Licenses are Better Solutions than IP Waiver, Says IFPMA Head 16/05/2021 Elaine Ruth Fletcher In preparation for the next pandemic, the COVAX global vaccine facility “needs a pot of money, where they can be early movers” in competing for, and securing, vaccine doses. That could help scenarios like the ones seen recently, in which rich countries cornered the market on the first available COVID-19 vaccines, leading to severe shortages […] Continue reading -> Moderna Signs Landmark Agreement With COVAX For 500 Million mRNA Vaccine Doses – WHO Asks G7 For US$20 Billion In COVID Finance 03/05/2021 Svĕt Lustig Vijay Gavi, The Vaccine Alliance, has secured half a billion doses of Moderna’s mRNA vaccine for the COVAX global vaccine facility in a landmark agreement that will deepen vaccination coverage in poor countries around the world, Gavi said on Monday. Meanwhile, Sweden announced that it will donate one million doses of the AstraZeneca vaccine to the […] Continue reading -> China May Become World’s Biggest Vaccine Supplier As India Defaults On Global Deliveries 28/04/2021 Kerry Cullinan As India restricts COVID-19 vaccine exports to address its domestic surge, the World Health Organization (WHO) is poised to give the Chinese vaccine, Sinopharm, emergency use listing (EUL) this week – potentially catapulting China into becoming the biggest global supplier of COVID-19 vaccines for low- and middle-income countries (LMIC). However, Sinopharm is reported to be […] Continue reading -> Ambitious Push to Resume Routine Immunisations to Save 50 Million Lives – COVAX Waits for Indian Vaccines 26/04/2021 Kerry Cullinan Fifty countries have not yet resumed routine immunisations disrupted by the COVID-19 pandemic, affecting 228 million people – mainly children – and there have already been serious measles outbreaks in Yemen, Pakistan and the Democratic Republic of the Congo, according to World Health Organization (WHO) director general Dr Tedros Adhanom Ghebreyusus. To address this, the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Challenges Pfizer and Moderna to Openly Share Their Know-How to Accelerate COVID Vaccine Production 02/07/2021 Elaine Ruth Fletcher In his most explicit appeal to date, WHO’s Director General Dr Tedros Adhanom Ghebreyesus called upon the global leaders in COVID mRNA vaccine manufacturing – Pfizer/BioNTech and Moderna to “share their know-how” in vaccine manufacturing with more manufacturers, particularly in low- and middle-income countries. The WHO DG also called upon countries that are beginning to […] Continue reading -> COVAX Shortcomings Under Microscope Ahead of Gavi, Vaccine Alliance Board Meeting 22/06/2021 Elaine Ruth Fletcher & Svĕt Lustig Vijay As the board of Gavi, The Vaccine Alliance is set to meet this Wednesday and Thursday, the COVAX global vaccine facility – a cornerstone of the global health sector response on vaccine access – is coming under increased fire for its shortcomings. A bitter opinion piece by Médecins Sans Frontières, published today, has called for […] Continue reading -> BREAKING – United States Unveils Global Vaccine Sharing Scheme for 80 Million Doses by End June 03/06/2021 Editorial team United States President Joe Biden on Thusday unveiled a detailed strategy for sharing 80 million surplus US COVID-19 vaccine doses with other countries in need by the end of June. A detailed allocation plan for the first 25 million of those vaccine doses calls for sharing 75% through the WHO-cosponsored COVAX global vaccine facility – […] Continue reading -> Sustainable COVAX Vaccine Funding & Voluntary Manufacturing Licenses are Better Solutions than IP Waiver, Says IFPMA Head 16/05/2021 Elaine Ruth Fletcher In preparation for the next pandemic, the COVAX global vaccine facility “needs a pot of money, where they can be early movers” in competing for, and securing, vaccine doses. That could help scenarios like the ones seen recently, in which rich countries cornered the market on the first available COVID-19 vaccines, leading to severe shortages […] Continue reading -> Moderna Signs Landmark Agreement With COVAX For 500 Million mRNA Vaccine Doses – WHO Asks G7 For US$20 Billion In COVID Finance 03/05/2021 Svĕt Lustig Vijay Gavi, The Vaccine Alliance, has secured half a billion doses of Moderna’s mRNA vaccine for the COVAX global vaccine facility in a landmark agreement that will deepen vaccination coverage in poor countries around the world, Gavi said on Monday. Meanwhile, Sweden announced that it will donate one million doses of the AstraZeneca vaccine to the […] Continue reading -> China May Become World’s Biggest Vaccine Supplier As India Defaults On Global Deliveries 28/04/2021 Kerry Cullinan As India restricts COVID-19 vaccine exports to address its domestic surge, the World Health Organization (WHO) is poised to give the Chinese vaccine, Sinopharm, emergency use listing (EUL) this week – potentially catapulting China into becoming the biggest global supplier of COVID-19 vaccines for low- and middle-income countries (LMIC). However, Sinopharm is reported to be […] Continue reading -> Ambitious Push to Resume Routine Immunisations to Save 50 Million Lives – COVAX Waits for Indian Vaccines 26/04/2021 Kerry Cullinan Fifty countries have not yet resumed routine immunisations disrupted by the COVID-19 pandemic, affecting 228 million people – mainly children – and there have already been serious measles outbreaks in Yemen, Pakistan and the Democratic Republic of the Congo, according to World Health Organization (WHO) director general Dr Tedros Adhanom Ghebreyusus. To address this, the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVAX Shortcomings Under Microscope Ahead of Gavi, Vaccine Alliance Board Meeting 22/06/2021 Elaine Ruth Fletcher & Svĕt Lustig Vijay As the board of Gavi, The Vaccine Alliance is set to meet this Wednesday and Thursday, the COVAX global vaccine facility – a cornerstone of the global health sector response on vaccine access – is coming under increased fire for its shortcomings. A bitter opinion piece by Médecins Sans Frontières, published today, has called for […] Continue reading -> BREAKING – United States Unveils Global Vaccine Sharing Scheme for 80 Million Doses by End June 03/06/2021 Editorial team United States President Joe Biden on Thusday unveiled a detailed strategy for sharing 80 million surplus US COVID-19 vaccine doses with other countries in need by the end of June. A detailed allocation plan for the first 25 million of those vaccine doses calls for sharing 75% through the WHO-cosponsored COVAX global vaccine facility – […] Continue reading -> Sustainable COVAX Vaccine Funding & Voluntary Manufacturing Licenses are Better Solutions than IP Waiver, Says IFPMA Head 16/05/2021 Elaine Ruth Fletcher In preparation for the next pandemic, the COVAX global vaccine facility “needs a pot of money, where they can be early movers” in competing for, and securing, vaccine doses. That could help scenarios like the ones seen recently, in which rich countries cornered the market on the first available COVID-19 vaccines, leading to severe shortages […] Continue reading -> Moderna Signs Landmark Agreement With COVAX For 500 Million mRNA Vaccine Doses – WHO Asks G7 For US$20 Billion In COVID Finance 03/05/2021 Svĕt Lustig Vijay Gavi, The Vaccine Alliance, has secured half a billion doses of Moderna’s mRNA vaccine for the COVAX global vaccine facility in a landmark agreement that will deepen vaccination coverage in poor countries around the world, Gavi said on Monday. Meanwhile, Sweden announced that it will donate one million doses of the AstraZeneca vaccine to the […] Continue reading -> China May Become World’s Biggest Vaccine Supplier As India Defaults On Global Deliveries 28/04/2021 Kerry Cullinan As India restricts COVID-19 vaccine exports to address its domestic surge, the World Health Organization (WHO) is poised to give the Chinese vaccine, Sinopharm, emergency use listing (EUL) this week – potentially catapulting China into becoming the biggest global supplier of COVID-19 vaccines for low- and middle-income countries (LMIC). However, Sinopharm is reported to be […] Continue reading -> Ambitious Push to Resume Routine Immunisations to Save 50 Million Lives – COVAX Waits for Indian Vaccines 26/04/2021 Kerry Cullinan Fifty countries have not yet resumed routine immunisations disrupted by the COVID-19 pandemic, affecting 228 million people – mainly children – and there have already been serious measles outbreaks in Yemen, Pakistan and the Democratic Republic of the Congo, according to World Health Organization (WHO) director general Dr Tedros Adhanom Ghebreyusus. To address this, the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
BREAKING – United States Unveils Global Vaccine Sharing Scheme for 80 Million Doses by End June 03/06/2021 Editorial team United States President Joe Biden on Thusday unveiled a detailed strategy for sharing 80 million surplus US COVID-19 vaccine doses with other countries in need by the end of June. A detailed allocation plan for the first 25 million of those vaccine doses calls for sharing 75% through the WHO-cosponsored COVAX global vaccine facility – […] Continue reading -> Sustainable COVAX Vaccine Funding & Voluntary Manufacturing Licenses are Better Solutions than IP Waiver, Says IFPMA Head 16/05/2021 Elaine Ruth Fletcher In preparation for the next pandemic, the COVAX global vaccine facility “needs a pot of money, where they can be early movers” in competing for, and securing, vaccine doses. That could help scenarios like the ones seen recently, in which rich countries cornered the market on the first available COVID-19 vaccines, leading to severe shortages […] Continue reading -> Moderna Signs Landmark Agreement With COVAX For 500 Million mRNA Vaccine Doses – WHO Asks G7 For US$20 Billion In COVID Finance 03/05/2021 Svĕt Lustig Vijay Gavi, The Vaccine Alliance, has secured half a billion doses of Moderna’s mRNA vaccine for the COVAX global vaccine facility in a landmark agreement that will deepen vaccination coverage in poor countries around the world, Gavi said on Monday. Meanwhile, Sweden announced that it will donate one million doses of the AstraZeneca vaccine to the […] Continue reading -> China May Become World’s Biggest Vaccine Supplier As India Defaults On Global Deliveries 28/04/2021 Kerry Cullinan As India restricts COVID-19 vaccine exports to address its domestic surge, the World Health Organization (WHO) is poised to give the Chinese vaccine, Sinopharm, emergency use listing (EUL) this week – potentially catapulting China into becoming the biggest global supplier of COVID-19 vaccines for low- and middle-income countries (LMIC). However, Sinopharm is reported to be […] Continue reading -> Ambitious Push to Resume Routine Immunisations to Save 50 Million Lives – COVAX Waits for Indian Vaccines 26/04/2021 Kerry Cullinan Fifty countries have not yet resumed routine immunisations disrupted by the COVID-19 pandemic, affecting 228 million people – mainly children – and there have already been serious measles outbreaks in Yemen, Pakistan and the Democratic Republic of the Congo, according to World Health Organization (WHO) director general Dr Tedros Adhanom Ghebreyusus. To address this, the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Sustainable COVAX Vaccine Funding & Voluntary Manufacturing Licenses are Better Solutions than IP Waiver, Says IFPMA Head 16/05/2021 Elaine Ruth Fletcher In preparation for the next pandemic, the COVAX global vaccine facility “needs a pot of money, where they can be early movers” in competing for, and securing, vaccine doses. That could help scenarios like the ones seen recently, in which rich countries cornered the market on the first available COVID-19 vaccines, leading to severe shortages […] Continue reading -> Moderna Signs Landmark Agreement With COVAX For 500 Million mRNA Vaccine Doses – WHO Asks G7 For US$20 Billion In COVID Finance 03/05/2021 Svĕt Lustig Vijay Gavi, The Vaccine Alliance, has secured half a billion doses of Moderna’s mRNA vaccine for the COVAX global vaccine facility in a landmark agreement that will deepen vaccination coverage in poor countries around the world, Gavi said on Monday. Meanwhile, Sweden announced that it will donate one million doses of the AstraZeneca vaccine to the […] Continue reading -> China May Become World’s Biggest Vaccine Supplier As India Defaults On Global Deliveries 28/04/2021 Kerry Cullinan As India restricts COVID-19 vaccine exports to address its domestic surge, the World Health Organization (WHO) is poised to give the Chinese vaccine, Sinopharm, emergency use listing (EUL) this week – potentially catapulting China into becoming the biggest global supplier of COVID-19 vaccines for low- and middle-income countries (LMIC). However, Sinopharm is reported to be […] Continue reading -> Ambitious Push to Resume Routine Immunisations to Save 50 Million Lives – COVAX Waits for Indian Vaccines 26/04/2021 Kerry Cullinan Fifty countries have not yet resumed routine immunisations disrupted by the COVID-19 pandemic, affecting 228 million people – mainly children – and there have already been serious measles outbreaks in Yemen, Pakistan and the Democratic Republic of the Congo, according to World Health Organization (WHO) director general Dr Tedros Adhanom Ghebreyusus. To address this, the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Moderna Signs Landmark Agreement With COVAX For 500 Million mRNA Vaccine Doses – WHO Asks G7 For US$20 Billion In COVID Finance 03/05/2021 Svĕt Lustig Vijay Gavi, The Vaccine Alliance, has secured half a billion doses of Moderna’s mRNA vaccine for the COVAX global vaccine facility in a landmark agreement that will deepen vaccination coverage in poor countries around the world, Gavi said on Monday. Meanwhile, Sweden announced that it will donate one million doses of the AstraZeneca vaccine to the […] Continue reading -> China May Become World’s Biggest Vaccine Supplier As India Defaults On Global Deliveries 28/04/2021 Kerry Cullinan As India restricts COVID-19 vaccine exports to address its domestic surge, the World Health Organization (WHO) is poised to give the Chinese vaccine, Sinopharm, emergency use listing (EUL) this week – potentially catapulting China into becoming the biggest global supplier of COVID-19 vaccines for low- and middle-income countries (LMIC). However, Sinopharm is reported to be […] Continue reading -> Ambitious Push to Resume Routine Immunisations to Save 50 Million Lives – COVAX Waits for Indian Vaccines 26/04/2021 Kerry Cullinan Fifty countries have not yet resumed routine immunisations disrupted by the COVID-19 pandemic, affecting 228 million people – mainly children – and there have already been serious measles outbreaks in Yemen, Pakistan and the Democratic Republic of the Congo, according to World Health Organization (WHO) director general Dr Tedros Adhanom Ghebreyusus. To address this, the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
China May Become World’s Biggest Vaccine Supplier As India Defaults On Global Deliveries 28/04/2021 Kerry Cullinan As India restricts COVID-19 vaccine exports to address its domestic surge, the World Health Organization (WHO) is poised to give the Chinese vaccine, Sinopharm, emergency use listing (EUL) this week – potentially catapulting China into becoming the biggest global supplier of COVID-19 vaccines for low- and middle-income countries (LMIC). However, Sinopharm is reported to be […] Continue reading -> Ambitious Push to Resume Routine Immunisations to Save 50 Million Lives – COVAX Waits for Indian Vaccines 26/04/2021 Kerry Cullinan Fifty countries have not yet resumed routine immunisations disrupted by the COVID-19 pandemic, affecting 228 million people – mainly children – and there have already been serious measles outbreaks in Yemen, Pakistan and the Democratic Republic of the Congo, according to World Health Organization (WHO) director general Dr Tedros Adhanom Ghebreyusus. To address this, the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Ambitious Push to Resume Routine Immunisations to Save 50 Million Lives – COVAX Waits for Indian Vaccines 26/04/2021 Kerry Cullinan Fifty countries have not yet resumed routine immunisations disrupted by the COVID-19 pandemic, affecting 228 million people – mainly children – and there have already been serious measles outbreaks in Yemen, Pakistan and the Democratic Republic of the Congo, according to World Health Organization (WHO) director general Dr Tedros Adhanom Ghebreyusus. To address this, the […] Continue reading -> Posts navigation Older postsNewer posts